Though on the Rise, the Transradial Approach to Primary PCI Remains Underused

There is evidence to support the use of the transradial approach to coronary angioplasty. Several randomized studies have shown reduced bleeding and vascular complications when adopted, compared against patients treated with the femoral approach. There are also studies and meta-analysis suggesting that, in the context of primary PCI, the benefit would be even bigger, with significant events rate reduction (even mortality rate).

El uso del acceso radial en la angioplastia primaria crece pero aún no es muy utilizado

This study aims at defining the different patient, operator and institution factors that may or may not contribute to adopting the transradial approach.


Read also: Eficácia do stent de micromalha na angioplastia carotídea”.


The NCDR CathPCI registry included 692,433 patients undergoing primary PCI between 2009 and 2015. Only 12% of these patients (n=82,618) were treated via transracial access site.

 

Even though there are geographical differences, the use of the transradial approach has been increasing, going from 2% in 2009 to 23% in 2015,

 

Age, sex, cardiogenic shock, prior MI, operators starting before 2012, and non-academic institutions, are the factors tilting the scales for the femoral approach.


Read also: A reparação da valva mitral com Mitraclip é segura em pacientes de alto risco”.


When operators choose the transradial access site, there is significant reduction in bleeding, and when institutions adopt it, there is also mortality reduction.

 

Conclusion

Although the transradial approach to primary PCI is growing, it remains largely underused. 

 

Editorial Comment

The present analysis suggests that the evidence in favor of the transradial approach has had a positive impact in use, with a close to ten-fold increase in the last 6 years. However, in the US, figures are far lower than those reported by most European countries. Whether or not Latin America is adopting the transradial approach remains unclear, though intuitively, we should follow our European colleagues.

 

Título original: Variation in the Adoption of Transradial Access for ST-Segment Elevation Myocardial Infarction. Insights from the NCDR CathPCI Registry.

Reference: Javier A. Valle et al. J Am Coll Cardiol Intv 2017. Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....